BiomX Inc.

Ownership Transactions Reported by 23 Insiders

Symbol
PHGE on NYSE
Industry
Biological Products, (No Diagnostic Substances)
Location
22 Einstein St., Floor 4, Ness Ziona, Israel

Insiders trading volume in the past year

BiomX Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
OrbiMed Israel BioFund GP Limited Partnership 10%+ Owner $5.25M -$9.28K -0.18% May 15, 2024
James E. Flynn Director, *Director by Deputization $2.32M Apr 14, 2025
Cystic Fibrosis Foundation 10%+ Owner $1.66M Feb 26, 2025
Chidozie Ugwumba Exit Form 4 - former 10% owner $1.02M Oct 17, 2022
Jonas Grossman Director $127K Mar 29, 2022
Jonathan Solomon Chief Executive Officer, Director $118K Apr 14, 2025
Gbolahan Amusa Director $89.4K Mar 29, 2022
Merav Bassan Chief Development Officer $74.1K Apr 14, 2025
Marina Wolfson Chief Financial Officer $63.8K Apr 14, 2025
Assaf Oron Chief Business Officer $9.84K Sep 16, 2024
Paul J. Sekhri Director $4.25K Jul 28, 2021
Jesse Goodman Director Apr 14, 2025
Avraham Gabay Interim CFO Dec 6, 2023
Gregory Merril Director Apr 14, 2025
Jonathan Leff Director Apr 14, 2025
Susan Blum Director Apr 14, 2025
Russell Greig Director Apr 14, 2025
Thomas Layton Walton 10%+ Owner Dec 31, 2021
Dambach Michael E. Director Aug 21, 2023
Marks Jason M. Director Aug 21, 2023
Eddie Williams Director Apr 14, 2025
Lynne Sullivan Director Mar 1, 2023
Alan Moses Director Apr 14, 2025

Recent Insider Transactions by Companies or Individuals for BiomX Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.